Source: The West Bend News

The Antwerp Rotary Club met on Thursday, September 17 at the VFW post #5087. After the formalities of the Rotarian meeting, Randy and Pam Daeger spoke about their experiences with COVID. Randy and Pam were cases 2 and 3 in Paulding County. They said their experiences were very different from each other and they aren’t quite sure what their point of contact was.

One evening in April they drove home from Toledo and Pam started feeling bad. The next day Randy had a fever, but didn’t feel that bad. Pam was taken to Parkview and put in isolation and given oxygen. Her and Randy were both tested and came back positive. 

Pam and Randy were separated at that point and Pam was very stressed with not being able to see people in her hour of need, “I don’t want to die alone”, she pleaded with Randy.

The hospital immediately started her on Hydroxychloroquine. With family and friends praying for her, in six days she began to recover and was sent home with two more doses of the drug.

She still had some breathing issues and she said that you really do lose your sense of taste! She especially appreciates all the work Janet Zeedyk, PA, Paulding County Hospital, did for her.

Though, the COVID-19 wasn’t bad for Randy, it certainly was for Pam. They want to remind everyone to take extra precautions to protect yourself and those around you. 

Related: How hydroxychloroquine works at the cellular level

France: Natural history of COVID-19 and therapeutic options (hydroxychloroquine, azithromycin and zinc may represent the best current theraputic option)


Ghana: “HCQ and AZ associated with viral clearance in COVID-19 patients.” Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study update: Now 88 international studies (51 peer reviewed) show positive hydroxychloroquine treatment outcomes

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »